Related Experiment Video
Updated: Jun 4, 2026

07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Metastasis: new perspectives on an old problem.
Sandra Kraljevic Pavelic1, Mirela Sedic, Hrvojka Bosnjak
1Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia. sandrakp@biotech.uniri.hr
Molecular Cancer
|February 24, 2011
Summary
Metastasis remains complex, but new models integrating serial and parallel processes, alongside cancer stem cell research, are improving our understanding of tumor spread and therapy resistance. This knowledge advances individualized cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis, the spread of cancer, is poorly understood, with existing hypotheses failing to fully explain clinical observations.
- Few metastasis-inducing proteins have been validated, leaving metastasis as a significant challenge in cancer treatment.
Purpose of the Study:
- To provide an overview of the molecular mechanisms driving metastasis.
- To discuss recent advancements in understanding metastasis, including novel models and cancer stem cell research.
- To highlight the role of global molecular profiling, such as proteomics, in cancer research.
Main Methods:
- Review of current scientific literature on cancer metastasis.
- Analysis of a novel metastatic model integrating serial and parallel processes.
- Discussion of cancer stem cell identification, isolation, and molecular characterization.
- Exploration of findings from global molecular profiling strategies, including proteomics.
Main Results:
- A novel metastatic model offers a more comprehensive explanation for metastasis compared to previous hypotheses.
- Cancer stem cells are identified as key players in tumor proliferation, self-renewal, and tumorigenesis.
- Global molecular profiling, particularly proteomics, yields new insights into the molecular events of metastasis.
Conclusions:
- Understanding the molecular basis of metastasis and cancer stem cells is crucial for developing targeted therapies.
- Advancements in understanding metastasis pave the way for a new era of individualized cancer therapy.
- Proteomics and other profiling strategies are powerful tools for unraveling the complexities of cancer progression.
More Related Videos
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

